Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Arthur Brody

    TitleProfessor In Residence
    SchoolUniversity of California, San Diego
    Address9500 Gilman Drive #0603
    CA La Jolla 92093
    vCardDownload vCard

      Collapse Biography 
      Collapse Education and Training
      UCLAResidency1994Department of Psychiatry
      Tufts UniversityM.D.1990School of Medicine
      Vassar CollegeB.A.1986
      Collapse Awards and Honors
      UCLA Department of Psychiatry2009  - 2012Richard Metzner Endowed Chair
      Neuropsychopharmacology2013  - 2015Reviewer Appreciation Award
      VA Clinical Science Research and Development Services  - 2009Certificate of Appreciation
      American Psychiatric Association  - 2008Distinguished Fellow
      Department of Veterans Affairs2003  - 2003Goal Sharing Award
      National Alliance for Research on Schizophrenia and Depression1995  - 1997Daniel X. Freeman Award
      Vassar College1982  - 1986Cum Laude

      Collapse Overview 
      Collapse Overview
      Research and Clinical Interests: Tobacco Use Disorder; Positron Emission Tomography; Treatment of Cigarette Smoking

      Collapse Research 
      Collapse Research Activities and Funding
      Cross-species studies of smoking effects on cognition and neuroinflammation in HIV
      NIH/NIDA R01DA044909Aug 1, 2017 - Jul 31, 2022
      Role: Co-Principal Investigator
      Nicotinic Acetylcholine Receptor Density and Veteran Cigarette Smokers
      VA I01CX000412Jan 1, 2013 - Dec 31, 2017
      Role: Principal Investigator
      Brain Nicotine Receptor Density &Response to Nicotine Patch
      NIH/NIDA R01DA020872Sep 30, 2005 - Jun 30, 2014
      Role: Principal Investigator
      Treatments for Nicotine Dependence: Brain Mechanisms
      NIH/NIDA R01DA015059Sep 30, 2002 - Aug 31, 2007
      Role: Principal Investigator

      Collapse ORNG Applications 
      Collapse Featured Publications

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Xie J, Douglas PK, Wu YN, Brody A, Anderson AE. Decoding the encoding of functional brain networks: An fMRI classification comparison of non-negative matrix factorization (NMF), independent component analysis (ICA), and sparse coding algorithms. J Neurosci Methods. 2017 Apr 15; 282:81-94. PMID: 28322859.
        View in: PubMed
      2. Brody A, Hubert R, Enoki R, Garcia LY, Mamoun MS, Okita K, London ED, Nurmi EL, Seaman LC, Mandelkern MA. Effect of Cigarette Smoking on a Marker for Neuroinflammation: A [11C]DAA1106 Positron Emission Tomography Study. Neuropsychopharmacology. 2017 Jul; 42(8):1630-1639. PMID: 28262740.
        View in: PubMed
      3. Sultzer DL, Melrose RJ, Riskin-Jones H, Narvaez TA, Veliz J, Ando TK, Juarez KO, Harwood DG, Brody A, Mandelkern MA. Cholinergic Receptor Binding in Alzheimer Disease and Healthy Aging: Assessment In Vivo with Positron Emission Tomography Imaging. Am J Geriatr Psychiatry. 2017 Apr; 25(4):342-353. PMID: 28162919.
        View in: PubMed
      4. Zanchi D, Brody A, Borgwardt S, Haller S. Sex Effects on Smoking Cue Perception in Non-Smokers, Smokers, and Ex-Smokers: A Pilot Study. Front Psychiatry. 2016; 7:187. PMID: 27909413.
        View in: PubMed
      5. Brody A, Zorick T, Hubert R, Hellemann GS, Balali S, Kawasaki SS, Garcia LY, Enoki R, Abraham P, Young P, McCreary C. Combination Extended Smoking Cessation Treatment Plus Home Visits for Smokers With Schizophrenia: A Randomized Controlled Trial. Nicotine Tob Res. 2017 Jan; 19(1):68-76. PMID: 27613888.
        View in: PubMed
      6. Brody A, Hubert R, Mamoun MS, Enoki R, Garcia LY, Abraham P, Young P, Mandelkern MA. Nicotinic acetylcholine receptor availability in cigarette smokers: effect of heavy caffeine or marijuana use. Psychopharmacology (Berl). 2016 Sep; 233(17):3249-57. PMID: 27370018; PMCID: PMC4982797 [Available on 09/01/17].
      7. Zanchi D, Brody A, Montandon ML, Kopel R, Emmert K, Preti MG, Van De Ville D, Haller S. Cigarette smoking leads to persistent and dose-dependent alterations of brain activity and connectivity in anterior insula and anterior cingulate. Addict Biol. 2015 Nov; 20(6):1033-41. PMID: 26303184.
        View in: PubMed
      8. Dubroff JG, Doot RK, Falcone M, Schnoll RA, Ray R, Tyndale RF, Brody A, Hou C, Schmitz A, Lerman C. Decreased Nicotinic Receptor Availability in Smokers with Slow Rates of Nicotine Metabolism. J Nucl Med. 2015 Nov; 56(11):1724-9. PMID: 26272810; PMCID: PMC4646418.
      9. Brody A, McClernon FJ. Prediction of smoking cessation with treatment: the emerging contribution of brain imaging research. Neuropsychopharmacology. 2015 May; 40(6):1309-10. PMID: 25868069; PMCID: PMC4397413.
      10. Mamoun M, Bergen AW, Shieh J, Wiggins A, Brody A. Biomarkers of Response to Smoking Cessation Pharmacotherapies: Progress to Date. CNS Drugs. 2015 May; 29(5):359-69. PMID: 25895022; PMCID: PMC4470763.
      11. Zorick T, Mandelkern MA, Brody A. A naturalistic study of the association between antidepressant treatment and outcome of smoking cessation treatment. J Clin Psychiatry. 2014 Dec; 75(12):e1433-8. PMID: 25551240; PMCID: PMC4666295.
      12. Brody A, Okita K, Shieh J, Liang L, Hubert R, Mamoun M, Farahi J, Mandelkern MA. Radiation dosimetry and biodistribution of the translocator protein radiotracer [(11)C]DAA1106 determined with PET/CT in healthy human volunteers. Nucl Med Biol. 2014 Nov-Dec; 41(10):871-5. PMID: 25156039; PMCID: PMC4192057.
      13. Brody A, Mukhin AG, Mamoun MS, Luu T, Neary M, Liang L, Shieh J, Sugar CA, Rose JE, Mandelkern MA. Brain nicotinic acetylcholine receptor availability and response to smoking cessation treatment: a randomized trial. JAMA Psychiatry. 2014 Jul 01; 71(7):797-805. PMID: 24850280; PMCID: PMC4634637.
      14. Ray LA, Courtney KE, Ghahremani DG, Miotto K, Brody A, London ED. Varenicline, naltrexone, and their combination for heavy-drinking smokers: preliminary neuroimaging findings. Am J Drug Alcohol Abuse. 2015 Jan; 41(1):35-44. PMID: 24949564; PMCID: PMC4365972.
      15. Ray LA, Courtney KE, Ghahremani DG, Miotto K, Brody A, London ED. Varenicline, low dose naltrexone, and their combination for heavy-drinking smokers: human laboratory findings. Psychopharmacology (Berl). 2014 Oct; 231(19):3843-53. PMID: 24733235; PMCID: PMC4161630.
      16. Storage S, Mandelkern MA, Phuong J, Kozman M, Neary MK, Brody A. A positive relationship between harm avoidance and brain nicotinic acetylcholine receptor availability. Psychiatry Res. 2013 Dec 30; 214(3):415-21. PMID: 24148908; PMCID: PMC3851586.
      17. Xu J, Fregni F, Brody A, Rahman AS. Transcranial direct current stimulation reduces negative affect but not cigarette craving in overnight abstinent smokers. Front Psychiatry. 2013; 4:112. PMID: 24065930; PMCID: PMC3778370.
      18. Le Foll B, Guranda M, Wilson AA, Houle S, Rusjan PM, Wing VC, Zawertailo L, Busto U, Selby P, Brody A, George TP, Boileau I. Elevation of dopamine induced by cigarette smoking: novel insights from a [11C]-+-PHNO PET study in humans. Neuropsychopharmacology. 2014 Jan; 39(2):415-24. PMID: 23954846; PMCID: PMC3870776.
      19. Potenza MN, Brody A. Commentary on Boileau et?al. (2013): Distinguishing D2/D3 dopaminergic contributions to addictions. Addiction. 2013 May; 108(5):964-5. PMID: 23587083; PMCID: PMC3732166.
      20. Jasinska AJ, Zorick T, Brody A, Stein EA. Dual role of nicotine in addiction and cognition: a review of neuroimaging studies in humans. Neuropharmacology. 2014 Sep; 84:111-22. PMID: 23474015; NIHMSID: NIHMS453326.
        View in: PubMed
      21. Jarcho JM, Feier NA, Bert A, Labus JA, Lee M, Stains J, Ebrat B, Groman SM, Tillisch K, Brody A, London ED, Mandelkern MA, Mayer EA. Diminished neurokinin-1 receptor availability in patients with two forms of chronic visceral pain. Pain. 2013 Jul; 154(7):987-96. PMID: 23582152; PMCID: PMC4294187.
      22. Brody A, Mukhin AG, Mamoun MS, Kozman M, Phuong J, Neary M, Luu T, Mandelkern MA. Treatment for tobacco dependence: effect on brain nicotinic acetylcholine receptor density. Neuropsychopharmacology. 2013 Jul; 38(8):1548-56. PMID: 23429692; PMCID: PMC3682149.
      23. Brody A, Mukhin AG, La Charite J, Ta K, Farahi J, Sugar CA, Mamoun MS, Vellios E, Archie M, Kozman M, Phuong J, Arlorio F, Mandelkern MA. Up-regulation of nicotinic acetylcholine receptors in menthol cigarette smokers. Int J Neuropsychopharmacol. 2013 Jun; 16(5):957-66. PMID: 23171716; PMCID: PMC3758251.
      24. Lotfipour S, Mandelkern M, Alvarez-Estrada M, Brody A. A single administration of low-dose varenicline saturates a4ß2* nicotinic acetylcholine receptors in the human brain. Neuropsychopharmacology. 2012 Jun; 37(7):1738-48. PMID: 22395733; PMCID: PMC3358744.
      25. Culbertson CS, Shulenberger S, De La Garza R, Newton TF, Brody A. VIRTUAL REALITY CUE EXPOSURE THERAPY FOR THE TREATMENT OF TOBACCO DEPENDENCE. J Cyber Ther Rehabil. 2012; 5(1):57-64. PMID: 25342999.
        View in: PubMed
      26. Liao Y, Tang J, Deng Q, Deng Y, Luo T, Wang X, Chen H, Liu T, Chen X, Brody A, Hao W. Bilateral fronto-parietal integrity in young chronic cigarette smokers: a diffusion tensor imaging study. PLoS One. 2011; 6(11):e26460. PMID: 22069452; PMCID: PMC3206030.
      27. Brody A, Cook IA. Manipulation of cigarette craving with transcranial magnetic stimulation. Biol Psychiatry. 2011 Oct 15; 70(8):702-3. PMID: 21967985; PMCID: PMC3379875.
      28. Anderson A, Bramen J, Douglas PK, Lenartowicz A, Cho A, Culbertson C, Brody A, Yuille AL, Cohen MS. Large Sample Group Independent Component Analysis of Functional Magnetic Resonance Imaging Using Anatomical Atlas-Based Reduction and Bootstrapped Clustering. Int J Imaging Syst Technol. 2011 Jun; 21(2):223-231. PMID: 22049263.
        View in: PubMed
      29. Brody A, Mandelkern MA, London ED, Khan A, Kozman D, Costello MR, Vellios EE, Archie MM, Bascom R, Mukhin AG. Effect of secondhand smoke on occupancy of nicotinic acetylcholine receptors in brain. Arch Gen Psychiatry. 2011 Sep; 68(9):953-60. PMID: 21536968; PMCID: PMC3380615.
      30. Lotfipour S, Mandelkern M, Brody A. Quantitative Molecular Imaging of Neuronal Nicotinic Acetylcholine Receptors in the Human Brain with A-85380 Radiotracers. Curr Med Imaging Rev. 2011 May 01; 7(2):107-112. PMID: 22773924.
        View in: PubMed
      31. Culbertson CS, Bramen J, Cohen MS, London ED, Olmstead RE, Gan JJ, Costello MR, Shulenberger S, Mandelkern MA, Brody A. Effect of bupropion treatment on brain activation induced by cigarette-related cues in smokers. Arch Gen Psychiatry. 2011 May; 68(5):505-15. PMID: 21199957; PMCID: PMC3214639.
      32. Brody A, London ED, Olmstead RE, Allen-Martinez Z, Shulenberger S, Costello MR, Abrams AL, Scheibal D, Farahi J, Shoptaw S, Mandelkern MA. Smoking-induced change in intrasynaptic dopamine concentration: effect of treatment for Tobacco Dependence. Psychiatry Res. 2010 Sep 30; 183(3):218-24. PMID: 20682457; PMCID: PMC2947623.
      33. Culbertson C, Nicolas S, Zaharovits I, London ED, De La Garza R, Brody A, Newton TF. Methamphetamine craving induced in an online virtual reality environment. Pharmacol Biochem Behav. 2010 Oct; 96(4):454-60. PMID: 20643158; PMCID: PMC2951480.
      34. Lee B, London ED, Poldrack RA, Farahi J, Nacca A, Monterosso JR, Mumford JA, Bokarius AV, Dahlbom M, Mukherjee J, Bilder RM, Brody A, Mandelkern MA. Striatal dopamine d2/d3 receptor availability is reduced in methamphetamine dependence and is linked to impulsivity. J Neurosci. 2009 Nov 25; 29(47):14734-40. PMID: 19940168; PMCID: PMC2822639.
      35. Azizian A, Nestor LJ, Payer D, Monterosso JR, Brody A, London ED. Smoking reduces conflict-related anterior cingulate activity in abstinent cigarette smokers performing a Stroop task. Neuropsychopharmacology. 2010 Feb; 35(3):775-82. PMID: 19907418; PMCID: PMC2813980.
      36. Costello MR, Mandelkern MA, Shoptaw S, Shulenberger S, Baker SK, Abrams AL, Xia C, London ED, Brody A. Effects of treatment for tobacco dependence on resting cerebral glucose metabolism. Neuropsychopharmacology. 2010 Feb; 35(3):605-12. PMID: 19865076; PMCID: PMC2813904.
      37. Brody A, Olmstead RE, Abrams AL, Costello MR, Khan A, Kozman D, Saxena S, Farahi J, London ED, Mandelkern MA. Effect of a history of major depressive disorder on smoking-induced dopamine release. Biol Psychiatry. 2009 Nov 01; 66(9):898-901. PMID: 19640507; PMCID: PMC2763050.
      38. Sharma A, Brody A. In vivo brain imaging of human exposure to nicotine and tobacco. Handb Exp Pharmacol. 2009; (192):145-71. PMID: 19184649; PMCID: PMC2893588.
      39. Xu J, Azizian A, Monterosso J, Domier CP, Brody A, Fong TW, London ED. Gender effects on mood and cigarette craving during early abstinence and resumption of smoking. Nicotine Tob Res. 2008 Nov; 10(11):1653-61. PMID: 18988078; PMCID: PMC2774521.
      40. Brody A, Mandelkern MA, Costello MR, Abrams AL, Scheibal D, Farahi J, London ED, Olmstead RE, Rose JE, Mukhin AG. Brain nicotinic acetylcholine receptor occupancy: effect of smoking a denicotinized cigarette. Int J Neuropsychopharmacol. 2009 Apr; 12(3):305-16. PMID: 18706128; PMCID: PMC2773668.
      41. Brody A, Mandelkern MA, Olmstead RE, Allen-Martinez Z, Scheibal D, Abrams AL, Costello MR, Farahi J, Saxena S, Monterosso J, London ED. Ventral striatal dopamine release in response to smoking a regular vs a denicotinized cigarette. Neuropsychopharmacology. 2009 Jan; 34(2):282-9. PMID: 18563061; PMCID: PMC2777990.
      42. Azizian A, Monterosso JR, Brody A, Simon SL, London ED. Severity of nicotine dependence moderates performance on perceptual-motor tests of attention. Nicotine Tob Res. 2008 Apr; 10(4):599-606. PMID: 18418782; PMCID: PMC2773663.
      43. Saxena S, Gorbis E, O'Neill J, Baker SK, Mandelkern MA, Maidment KM, Chang S, Salamon N, Brody A, Schwartz JM, London ED. Rapid effects of brief intensive cognitive-behavioral therapy on brain glucose metabolism in obsessive-compulsive disorder. Mol Psychiatry. 2009 Feb; 14(2):197-205. PMID: 18180761; PMCID: PMC2893580.
      44. Domier CP, Monterosso JR, Brody A, Simon SL, Mendrek A, Olmstead R, Jarvik ME, Cohen MS, London ED. Effects of cigarette smoking and abstinence on Stroop task performance. Psychopharmacology (Berl). 2007 Nov; 195(1):1-9. PMID: 17634928; PMCID: PMC2796691.
      45. Gershon Grand RB, Hwang S, Han J, George T, Brody A. Short-term naturalistic treatment outcomes in cigarette smokers with substance abuse and/or mental illness. J Clin Psychiatry. 2007 Jun; 68(6):892-8; quiz 980-1. PMID: 17592914; PMCID: PMC2893593.
      46. Brody A, Mandelkern MA, Olmstead RE, Jou J, Tiongson E, Allen V, Scheibal D, London ED, Monterosso JR, Tiffany ST, Korb A, Gan JJ, Cohen MS. Neural substrates of resisting craving during cigarette cue exposure. Biol Psychiatry. 2007 Sep 15; 62(6):642-51. PMID: 17217932; PMCID: PMC1992815.
      47. Xu J, Mendrek A, Cohen MS, Monterosso J, Simon S, Jarvik M, Olmstead R, Brody A, Ernst M, London ED. Effect of cigarette smoking on prefrontal cortical function in nondeprived smokers performing the Stroop Task. Neuropsychopharmacology. 2007 Jun; 32(6):1421-8. PMID: 17164821; PMCID: PMC2876092.
      48. Xu J, Mendrek A, Cohen MS, Monterosso J, Simon S, Brody A, Jarvik M, Rodriguez P, Ernst M, London ED. Effects of acute smoking on brain activity vary with abstinence in smokers performing the N-Back task: a preliminary study. Psychiatry Res. 2006 Dec 01; 148(2-3):103-9. PMID: 17088048; PMCID: PMC1817900.
      49. Brody A, Mandelkern MA, London ED, Olmstead RE, Farahi J, Scheibal D, Jou J, Allen V, Tiongson E, Chefer SI, Koren AO, Mukhin AG. Cigarette smoking saturates brain alpha 4 beta 2 nicotinic acetylcholine receptors. Arch Gen Psychiatry. 2006 Aug; 63(8):907-15. PMID: 16894067; PMCID: PMC2773659.
      50. Brody A, Mandelkern MA, Olmstead RE, Scheibal D, Hahn E, Shiraga S, Zamora-Paja E, Farahi J, Saxena S, London ED, McCracken JT. Gene variants of brain dopamine pathways and smoking-induced dopamine release in the ventral caudate/nucleus accumbens. Arch Gen Psychiatry. 2006 Jul; 63(7):808-16. PMID: 16818870; PMCID: PMC2873693.
      51. Saxena S, Brody A, Maidment KM, Baxter LR. Paroxetine treatment of compulsive hoarding. J Psychiatr Res. 2007 Sep; 41(6):481-7. PMID: 16790250; PMCID: PMC2876089.
      52. Obrzut SL, Koren AO, Mandelkern MA, Brody A, Hoh CK, London ED. Whole-body radiation dosimetry of 2-[18F]Fluoro-A-85380 in human PET imaging studies. Nucl Med Biol. 2005 Nov; 32(8):869-74. PMID: 16253812.
        View in: PubMed
      53. London ED, Berman SM, Voytek B, Simon SL, Mandelkern MA, Monterosso J, Thompson PM, Brody A, Geaga JA, Hong MS, Hayashi KM, Rawson RA, Ling W. Cerebral metabolic dysfunction and impaired vigilance in recently abstinent methamphetamine abusers. Biol Psychiatry. 2005 Nov 15; 58(10):770-8. PMID: 16095568.
        View in: PubMed
      54. Voytek B, Berman SM, Hassid BD, Simon SL, Mandelkern MA, Brody A, Monterosso J, Ling W, London ED. Differences in regional brain metabolism associated with marijuana abuse in methamphetamine abusers. Synapse. 2005 Aug; 57(2):113-5. PMID: 15906384.
        View in: PubMed
      55. Xu J, Mendrek A, Cohen MS, Monterosso J, Rodriguez P, Simon SL, Brody A, Jarvik M, Domier CP, Olmstead R, Ernst M, London ED. Brain activity in cigarette smokers performing a working memory task: effect of smoking abstinence. Biol Psychiatry. 2005 Jul 15; 58(2):143-50. PMID: 16038685; PMCID: PMC2773671.
      56. Mendrek A, Monterosso J, Simon SL, Jarvik M, Brody A, Olmstead R, Domier CP, Cohen MS, Ernst M, London ED. Working memory in cigarette smokers: comparison to non-smokers and effects of abstinence. Addict Behav. 2006 May; 31(5):833-44. PMID: 16009504; PMCID: PMC2773651.
      57. Brody A. Functional brain imaging of tobacco use and dependence. J Psychiatr Res. 2006 Aug; 40(5):404-18. PMID: 15979645; PMCID: PMC2876087.
      58. Baicy K, Bearden CE, Monterosso J, Brody A, Isaacson AJ, London ED. Common substrates of dysphoria in stimulant drug abuse and primary depression: therapeutic targets. Int Rev Neurobiol. 2005; 65:117-45. PMID: 16140055.
        View in: PubMed
      59. Brody A, Olmstead RE, London ED, Farahi J, Meyer JH, Grossman P, Lee GS, Huang J, Hahn EL, Mandelkern MA. Smoking-induced ventral striatum dopamine release. Am J Psychiatry. 2004 Jul; 161(7):1211-8. PMID: 15229053.
        View in: PubMed
      60. Saxena S, Brody A, Maidment KM, Smith EC, Zohrabi N, Katz E, Baker SK, Baxter LR. Cerebral glucose metabolism in obsessive-compulsive hoarding. Am J Psychiatry. 2004 Jun; 161(6):1038-48. PMID: 15169692.
        View in: PubMed
      61. Brody A, Mandelkern MA, Lee G, Smith E, Sadeghi M, Saxena S, Jarvik ME, London ED. Attenuation of cue-induced cigarette craving and anterior cingulate cortex activation in bupropion-treated smokers: a preliminary study. Psychiatry Res. 2004 Apr 30; 130(3):269-81. PMID: 15135160; PMCID: PMC2773650.
      62. Brody A, Mandelkern MA, Jarvik ME, Lee GS, Smith EC, Huang JC, Bota RG, Bartzokis G, London ED. Differences between smokers and nonsmokers in regional gray matter volumes and densities. Biol Psychiatry. 2004 Jan 01; 55(1):77-84. PMID: 14706428.
        View in: PubMed
      63. Saxena S, Brody A, Ho ML, Zohrabi N, Maidment KM, Baxter LR. Differential brain metabolic predictors of response to paroxetine in obsessive-compulsive disorder versus major depression. Am J Psychiatry. 2003 Mar; 160(3):522-32. PMID: 12611834.
        View in: PubMed
      64. Brody A, Mandelkern MA, London ED, Childress AR, Lee GS, Bota RG, Ho ML, Saxena S, Baxter LR, Madsen D, Jarvik ME. Brain metabolic changes during cigarette craving. Arch Gen Psychiatry. 2002 Dec; 59(12):1162-72. PMID: 12470133.
        View in: PubMed
      65. Saxena S, Brody A, Ho ML, Alborzian S, Maidment KM, Zohrabi N, Ho MK, Huang SC, Wu HM, Baxter LR. Differential cerebral metabolic changes with paroxetine treatment of obsessive-compulsive disorder vs major depression. Arch Gen Psychiatry. 2002 Mar; 59(3):250-61. PMID: 11879163.
        View in: PubMed
      66. Saxena S, Brody A, Ho ML, Alborzian S, Ho MK, Maidment KM, Huang SC, Wu HM, Au SC, Baxter LR. Cerebral metabolism in major depression and obsessive-compulsive disorder occurring separately and concurrently. Biol Psychiatry. 2001 Aug 01; 50(3):159-70. PMID: 11513814.
        View in: PubMed
      67. Brody A, Saxena S, Mandelkern MA, Fairbanks LA, Ho ML, Baxter LR. Brain metabolic changes associated with symptom factor improvement in major depressive disorder. Biol Psychiatry. 2001 Aug 01; 50(3):171-8. PMID: 11513815.
        View in: PubMed
      68. Brody A, Saxena S, Stoessel P, Gillies LA, Fairbanks LA, Alborzian S, Phelps ME, Huang SC, Wu HM, Ho ML, Ho MK, Au SC, Maidment K, Baxter LR. Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy: preliminary findings. Arch Gen Psychiatry. 2001 Jul; 58(7):631-40. PMID: 11448368.
        View in: PubMed
      69. Saxena S, Bota RG, Brody A. Brain-behavior relationships in obsessive-compulsive disorder. Semin Clin Neuropsychiatry. 2001 Apr; 6(2):82-101. PMID: 11296309.
        View in: PubMed
      70. Brody A, Barsom MW, Bota RG, Saxena S. Prefrontal-subcortical and limbic circuit mediation of major depressive disorder. Semin Clin Neuropsychiatry. 2001 Apr; 6(2):102-12. PMID: 11296310.
        View in: PubMed
      71. Brody A, Saxena S, Fairbanks LA, Alborzian S, Demaree HA, Maidment KM, Baxter LR. Personality changes in adult subjects with major depressive disorder or obsessive-compulsive disorder treated with paroxetine. J Clin Psychiatry. 2000 May; 61(5):349-55. PMID: 10847309.
        View in: PubMed
      72. Saxena S, Brody A, Maidment KM, Dunkin JJ, Colgan M, Alborzian S, Phelps ME, Baxter LR. Localized orbitofrontal and subcortical metabolic changes and predictors of response to paroxetine treatment in obsessive-compulsive disorder. Neuropsychopharmacology. 1999 Dec; 21(6):683-93. PMID: 10633474.
        View in: PubMed
      73. Brody A, Saxena S, Silverman DH, Alborzian S, Fairbanks LA, Phelps ME, Huang SC, Wu HM, Maidment K, Baxter LR. Brain metabolic changes in major depressive disorder from pre- to post-treatment with paroxetine. Psychiatry Res. 1999 Oct 11; 91(3):127-39. PMID: 10641577.
        View in: PubMed
      74. Brody A, Saxena S, Schwartz JM, Stoessel PW, Maidment K, Phelps ME, Baxter LR. FDG-PET predictors of response to behavioral therapy and pharmacotherapy in obsessive compulsive disorder. Psychiatry Res. 1998 Nov 09; 84(1):1-6. PMID: 9870412.
        View in: PubMed
      75. Saxena S, Brody A, Schwartz JM, Baxter LR. Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder. Br J Psychiatry Suppl. 1998; (35):26-37. PMID: 9829024.
        View in: PubMed
      76. Brown M, Shah PV, Brody A, Woods SM, Yager J. Litigation in residency training programs and suggested due process guidelines for "residents in trouble". Acad Psychiatry. 1994 Sep; 18(3):119-28. PMID: 24442464.
        View in: PubMed
      77. Brody A, Green R. Washington State's unscientific approach to the problem of repeat sex offenders. Bull Am Acad Psychiatry Law. 1994; 22(3):343-56. PMID: 7841506.
        View in: PubMed
      78. Brody A, Small GW. On early Alzheimer's disease presenting as pseudoseizures. Am J Geriatr Psychiatry. 1994; 2(1):90. PMID: 21629011.
        View in: PubMed
      Arthur's Networks
      Derived automatically from this person's publications.
      People in Profiles who have published with this person.
      Similar People
      People who share similar concepts with this person.
      Same Department